Refashioning dexpramipexole: A new horizon in eosinophilic asthma?

J Allergy Clin Immunol. 2023 Nov;152(5):1092-1094. doi: 10.1016/j.jaci.2023.09.019. Epub 2023 Sep 26.

Authors

Ruth P Cusack¹, Ibrahim Sulaiman², Gail M Gauvreau³

Affiliations

¹ Department of Respiratory Medicine, Galway University Hospitals, Galway, Ireland.
² Faculty of Medical Sciences, The University of the West Indies, Cave Hill Campus, Cave Hill, Barbados.
³ Faculty of Health Sciences, Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Electronic address: gauvreau@mcmaster.ca.

PMID: 37769877
DOI: 10.1016/j.jaci.2023.09.019

No abstract available

Keywords: Eosinophilic asthma; clinical trial; dexpramipexole; eosinophils.

Publication types

Editorial
Comment

MeSH terms

Asthma* / drug therapy
Eosinophils
Humans
Leukocyte Count
Pramipexole
Pulmonary Eosinophilia*

Substances

Pramipexole